The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Kiichi Ishiwata

Positron Medical Center

Tokyo Metropolitan Institute of Gerontology

1-1 Naka-cho

Itabashi-ku

Japan

[email]@pet.tmig.or.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Positron Medical Center, Tokyo Metropolitan Institute of Gerontology, 1-1 Naka-cho, Itabashi-ku, Japan. 1997 - 2008

References

  1. Successive positron emission tomography measurement of cerebral blood flow and neuroreceptors in the human brain: an 11C-SA4503 study. Ishiwata, K., Ishii, K., Kimura, Y., Kawamura, K., Oda, K., Sasaki, T., Sakata, M., Senda, M. Ann. Nucl. Med (2008) [Pubmed]
  2. In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically. Ishiwata, K., Kawamura, K., Yanai, K., Hendrikse, N.H. J. Nucl. Med. (2007) [Pubmed]
  3. Evaluation of (+)-p-[11C]methylvesamicol for mapping sigma1 receptors: a comparison with [11C]SA4503. Ishiwata, K., Kawamura, K., Yajima, K., QingGeLeTu, , Mori, H., Shiba, K. Nucl. Med. Biol. (2006) [Pubmed]
  4. Tumor viability evaluation by positron emission tomography with [18F]FDG in the liver metastasis rat model. Ishiwata, K., Liu, H.Y., Teramoto, K., Kawamura, K., Oda, K., Arii, S. Ann. Nucl. Med (2006) [Pubmed]
  5. A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptors. Ishiwata, K., Oda, K., Sakata, M., Kimura, Y., Kawamura, K., Oda, K., Sasaki, T., Naganawa, M., Chihara, K., Okubo, Y., Ishii, K. Ann. Nucl. Med (2006) [Pubmed]
  6. First visualization of adenosine A(2A) receptors in the human brain by positron emission tomography with [11C]TMSX. Ishiwata, K., Mishina, M., Kimura, Y., Oda, K., Sasaki, T., Ishii, K. Synapse (2005) [Pubmed]
  7. Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomography. Ishiwata, K., Tsukada, H., Kubota, K., Nariai, T., Harada, N., Kawamura, K., Kimura, Y., Oda, K., Iwata, R., Ishii, K. Nucl. Med. Biol. (2005) [Pubmed]
  8. Evaluation of O-[11C]methyl-L-tyrosine and O-[18F]fluoromethyl-L-tyrosine as tumor imaging tracers by PET. Ishiwata, K., Kawamura, K., Wang, W.F., Furumoto, S., Kubota, K., Pascali, C., Bogni, A., Iwata, R. Nucl. Med. Biol. (2004) [Pubmed]
  9. Evaluation of in vivo selective binding of [11C]doxepin to histamine H1 receptors in five animal species. Ishiwata, K., Kawamura, K., Wang, W.F., Tsukada, H., Harada, N., Mochizuki, H., Kimura, Y., Ishii, K., Iwata, R., Yanai, K. Nucl. Med. Biol. (2004) [Pubmed]
  10. Potential of [11C]TMSX for the evaluation of adenosine A2A receptors in the skeletal muscle by positron emission tomography. Ishiwata, K., Mizuno, M., Kimura, Y., Kawamura, K., Oda, K., Sasaki, T., Nakamura, Y., Muraoka, I., Ishii, K. Nucl. Med. Biol. (2004) [Pubmed]
  11. No reduction of dopamine transporter binding sites in mice following treatment with the TIQ analogue 1-benzyl-1,2,3,4-tetrahydroisoquinoline. Ishiwata, K., Koyanagi, Y., Abe, K., Kawamura, K., Taguchi, K., Saitoh, T., Toda, J., Sano, T. Brain Res. (2003) [Pubmed]
  12. Age-related changes of the binding of [3h]SA4503 to sigma1 receptors in the rat brain. Ishiwata, K., Kobayashi, T., Kawamura, K., Matsuno, K. Ann. Nucl. Med (2003) [Pubmed]
  13. Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands. Ishiwata, K., Kawamura, K., Kobayashi, T., Matsuno, K. Nucl. Med. Biol. (2003) [Pubmed]
  14. Preclinical studies on [11C]TMSX for mapping adenosine A2A receptors by positron emission tomography. Ishiwata, K., Wang, W.F., Kimura, Y., Kawamura, K., Ishii, K. Ann. Nucl. Med (2003) [Pubmed]
  15. Potential of an adenosine A2A receptor antagonist [11C]TMSX for myocardial imaging by positron emission tomography: a first human study. Ishiwata, K., Kawamura, K., Kimura, Y., Oda, K., Ishii, K. Ann. Nucl. Med (2003) [Pubmed]
  16. Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone. Ishiwata, K., Ogi, N., Hayakawa, N., Umegaki, H., Nagaoka, T., Oda, K., Toyama, H., Endo, K., Tanaka, A., Senda, M. Nucl. Med. Biol. (2002) [Pubmed]
  17. Preclinical studies on [11C]MPDX for mapping adenosine A1 receptors by positron emission tomography. Ishiwata, K., Nariai, T., Kimura, Y., Oda, K., Kawamura, K., Ishii, K., Senda, M., Wakabayashi, S., Shimada, J. Ann. Nucl. Med (2002) [Pubmed]
  18. Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imaging. Ishiwata, K., Ogi, N., Hayakawa, N., Oda, K., Nagaoka, T., Toyama, H., Suzuki, F., Endo, K., Tanaka, A., Senda, M. Ann. Nucl. Med (2002) [Pubmed]
  19. Mapping of CNS sigma(1) receptors in the conscious monkey: preliminary PET study with [(11)C]SA4503. Ishiwata, K., Tsukada, H., Kawamura, K., Kimura, Y., Nishiyama, S., Kobayashi, T., Matsuno, K., Senda, M. Synapse (2001) [Pubmed]
  20. Synthesis and preliminary evaluation of a carbon-11-labeled adenosine transporter blocker [(11)C]KF21562 . Ishiwata, K., Takai, H., Nonaka, H., Ishii, S., Simada, J., Senda, M. Nucl. Med. Biol. (2001) [Pubmed]
  21. [11C]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [11C]SA4503 binding was not by raclopride. Ishiwata, K., Kobayashi, T., Kawamura, K., Matsuno, K., Senda, M. Nucl. Med. Biol. (2001) [Pubmed]
  22. Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum. Ishiwata, K., Koyanagi, Y., Abe, K., Kawamura, K., Taguchi, K., Saitoh, T., Toda, J., Senda, M., Sano, T. J. Neurochem. (2001) [Pubmed]
  23. Effects of single and repeated administration of 1,2,3,4-tetrahydroisoquinoline analogs on the binding of [11C]raclopride to dopamine D2 receptors in the mouse brain. Ishiwata, K., Koyanagi, Y., Saitoh, T., Taguchi, K., Toda, J., Sano, T., Senda, M. J. Neural. Transm (2001) [Pubmed]
  24. Further characterization of a CNS adenosine A2a receptor ligand [11C]KF18446 with in vitro autoradiography and in vivo tissue uptake. Ishiwata, K., Ogi, N., Shimada, J., Nonaka, H., Tanaka, A., Suzuki, F., Senda, M. Ann. Nucl. Med (2000) [Pubmed]
  25. Evaluation of iodinated and brominated [11C]styrylxanthine derivatives as in vivo radioligands mapping adenosine A2A receptor in the central nervous system. Ishiwata, K., Shimada, J., Wang, W.F., Harakawa, H., Ishii, S., Kiyosawa, M., Suzuki, F., Senda, M. Ann. Nucl. Med (2000) [Pubmed]
  26. Search for PET probes for imaging the globus pallidus studied with rat brain ex vivo autoradiography. Ishiwata, K., Ogi, N., Shimada, J., Wang, W., Ishii, K., Tanaka, A., Suzuki, F., Senda, M. Ann. Nucl. Med (2000) [Pubmed]
  27. Quantitative ex vivo and in vitro receptor autoradiography using 11C-labeled ligands and an imaging plate: a study with a dopamine D2-like receptor ligand [11C]nemonapride. Ishiwata, K., Ogi, N., Tanaka, A., Senda, M. Nucl. Med. Biol. (1999) [Pubmed]
  28. Comparison of three PET dopamine D2-like receptor ligands, [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone, in rats. Ishiwata, K., Hayakawa, N., Ogi, N., Oda, K., Toyama, H., Endo, K., Tanaka, A., Senda, M. Ann. Nucl. Med (1999) [Pubmed]
  29. An alternative synthesis of [11C]raclopride for routine use. Ishiwata, K., Ishii, S., Senda, M. Ann. Nucl. Med (1999) [Pubmed]
  30. In vivo binding of [11C]nemonapride to sigma receptors in the cortex and cerebellum. Ishiwata, K., Senda, M. Nucl. Med. Biol. (1999) [Pubmed]
  31. Metabolite analysis of [11C]flumazenil in human plasma: assessment as the standardized value for quantitative PET studies. Ishiwata, K., Itou, T., Ohyama, M., Yamada, T., Mishina, M., Ishii, K., Nariai, T., Sasaki, T., Oda, K., Toyama, H., Senda, M. Ann. Nucl. Med (1998) [Pubmed]
  32. Synthesis and preliminary evaluation of [11C]NE-100 labeled in two different positions as a PET sigma receptor ligand. Ishiwata, K., Noguchi, J., Ishii, S., Hatano, K., Ito, K., Nabeshima, T., Senda, M. Nucl. Med. Biol. (1998) [Pubmed]
  33. Effects of reserpine treatment on the dopamine receptor binding of [3H/11C]nemonapride in the mouse and rat brain. Ishiwata, K., Onoguchi, K., Toyama, H., Noguchi, J., Senda, M. Ann. Nucl. Med (1997) [Pubmed]
  34. Carbon-11 labeled ethionine and propionine as tumor detecting agents. Ishiwata, K., Kasahara, C., Hatano, K., Ishii, S., Senda, M. Ann. Nucl. Med (1997) [Pubmed]
  35. Myocardial adenosine A2a receptor imaging of rabbit by PET with [11C]KF17837. Ishiwata, K., Sakiyama, Y., Sakiyama, T., Shimada, J., Toyama, H., Oda, K., Suzuki, F., Senda, M. Ann. Nucl. Med (1997) [Pubmed]
 
WikiGenes - Universities